Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 7/20 | 0.51 |
| ▸ | CTSS | P25774 | 6/20 | 0.51 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 2/20 | 0.40 |
| ▸ | CTSB | P07858 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28969869 | 0.87 | CTSK (0.67) | CTSKCTSSCA2TDP1CA1 | |
| SCHEMBL5559974 | 0.87 | CTSK (0.67) | CTSKCTSSCA2TDP1CA1 | |
| SCHEMBL28969873 | 0.83 | CTSS (0.69) | CTSKCTSSCA2TDP1CAPN1 | |
| SCHEMBL17880444 | 0.81 | CTSK (0.47) | CTSKCTSSCA2CA1CA7 | |
| SCHEMBL14737622 | 0.80 | KMT2A (0.53) | CTSKCTSSCA2TDP1CA1 | |
| SCHEMBL28969945 | 0.80 | KMT2A (0.53) | CTSKCTSSCA2TDP1CA1 | |
| SCHEMBL5741383 | 0.80 | KMT2A (0.53) | CTSKCTSSCA2TDP1CA1 | |
| SCHEMBL24097543 | 0.78 | CTSK (0.63) | CTSKCTSSCA2TDP1CA1 | |
| SCHEMBL29449290 | 0.78 | CTSS (0.46) | CTSKCTSSCA2CA1CA7 | |
| SCHEMBL6476152 | 0.77 | CTSK (0.49) | CTSKCTSSCA2CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115835860-A | Novel analogues of pterostilbene amino acids with carbonate for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis | 树顶分子生技股份有限公司 | 2023-03-21 | — | — | CN | disclosed |